Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 12126.154 | 0.9764 | 0.9221 | 0.6012 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 12126.154 | 0.9259 | 0.7595 | 0.6012 | |
MDA-MB-175-VII | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 12126.154 | 0.8928 | 0.6563 | 0.6012 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10643.142 | 0.9733 | 0.8978 | 0.5166 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10643.142 | 1.0120 | 1.0466 | 0.5166 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10643.142 | 0.9548 | 0.8289 | 0.5166 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 10643.142 | 0.9401 | 0.7745 | 0.5166 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 10643.142 | 1.0448 | 1.1770 | 0.5166 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 10643.142 | 0.9899 | 0.9610 | 0.5166 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 10643.142 | 0.9879 | 0.9535 | 0.5166 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 10643.142 | 0.9580 | 0.8407 | 0.5166 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 10643.142 | 1.0211 | 1.0826 | 0.5166 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10999.154 | 0.9287 | 0.8003 | 0.7027 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10999.154 | 1.0254 | 1.0727 | 0.7027 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10999.154 | 0.9768 | 0.9342 | 0.7027 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 10999.154 | 0.9490 | 0.8564 | 0.7027 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 10999.154 | 1.0309 | 1.0886 | 0.7027 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 10999.154 | 0.9616 | 0.8916 | 0.7027 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 10999.154 | 0.9711 | 0.9182 | 0.7027 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 10999.154 | 0.9140 | 0.7597 | 0.7027 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 10999.154 | 1.0607 | 1.1750 | 0.7027 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000171 | uM | 12379.167 | 1.0053 | 1.0204 | 0.5212 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000853 | uM | 12379.167 | 1.0496 | 1.1949 | 0.5212 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00427 | uM | 12379.167 | 0.9857 | 0.9454 | 0.5212 | |
MDA-MB-361 | HER2amp | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0213 | uM | 12379.167 | 0.9792 | 0.9210 | 0.5212 |